Healthcare Management News - Medtronic stent begins FDA pre-market approval process

Medtronic has submitted its first Pre-Market Approval (PMA) module to the U.S. Food and Drug Administration for the Endeavor Drug-Eluting Coronary Stent system, the company said Monday. This is the first step in the U.S.

http://c.moreover.com/click/here.pl?r404462004